Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Opportunistic infections news

Show

From To
Study identifies factors associated with mortality in HIV-positive people with cryptococcal meningitis

Rapid diagnosis and effective antifungal therapy are essential to reduce mortality rates in HIV-positive people with cryptococcal meningitis (CM), results of a study published in the online edition

Published
10 January 2014
By
Michael Carter
Early ART only increases TB IRIS risk for people with HIV who have a CD4 cell count below 50

A low CD4 cell count increases the risk of immune reconstitution inflammatory syndrome (IRIS) for people starting antiretroviral therapy (ART) within two weeks of treatment for tuberculosis (TB),

Published
28 November 2013
By
Michael Carter
Meningococcal Disease Risk 10-Fold Higher in People With HIV

People living with AIDS/HIV (PLWHA) are at 10-fold increased risk for contracting invasive meningococcal disease (IMD), according to a 12-year epidemiologic study published online October 29 in the Annals of Internal Medicine.

Published
01 November 2013
From
Medscape
Social problems and drug and alcohol problems common among people who develop AIDS despite long-term HIV care

Psychiatric, drug, alcohol and social care problems are highly prevalent among people who develop serious AIDS-defining illnesses well after their diagnosis with HIV, UK research published in Sexually Transmitted

Published
25 October 2013
By
Michael Carter
Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations

The updated label now includes information describing the use of the vaccine in preterm infants, children and adolescents with sickle cell disease who were previously vaccinated with the 23-valent pneumococcal polysaccharide vaccine, and adults with human immunodeficiency virus (HIV) infection who were previously vaccinated with the 23-valent pneumococcal polysaccharide vaccine.

Published
22 October 2013
From
Pfizer press release
Fungus targets HIV patients - study

Local researchers have discovered a new fungus that causes a potentially deadly disease in HIV-positive South Africans. The infection was caused by a newly described, but unnamed, opportunistic fungus in the type Emmonsia, and was fatal in three patients.

Published
15 October 2013
From
Independent Online
CD8 Activation Predicts Clinical Events on ART, But Only in 50+

CD8-cell activation predicts AIDS and non-AIDS conditions in people taking suppressive antiretroviral therapy (ART), but the association remained significant only in people 50 and older.

Published
01 October 2013
From
International AIDS Society
Novel vaccine approach to human cytomegalovirus found effective

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus.

Published
22 September 2013
From
UC Davis press release
Old HIV Sidekick Hits Unexpected Patient Group

Pneumocystis jirovecii pneumonia (PCP) -- a hallmark of the early days of the HIV/AIDS pandemic -- still crops up in the era of combination antiretroviral therapy, but, surprisingly, it's seen almost as often in long-term patients as in the newly infected.

Published
17 September 2013
From
MedPage Today HIV/AIDS
Hepatitis E virus infection associated with HIV and damage to gut mucosa, Zambian study shows

The prevalence of hepatitis E virus (HEV) infection is strongly associated with HIV status, results of a study conducted in Zambia and published in the online edition

Published
13 September 2013
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.